These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 33269425)

  • 21. The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers.
    Karila T; Laaksonen R; Jokelainen K; Himberg JJ; Seppälä T
    Metabolism; 1996 Jul; 45(7):844-7. PubMed ID: 8692019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
    Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
    Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.
    Bonnecaze AK; O'Connor T; Burns CA
    J Gen Intern Med; 2021 Jul; 36(7):2055-2064. PubMed ID: 33948794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of androgens on haemostasis.
    Winkler UH
    Maturitas; 1996 Jul; 24(3):147-55. PubMed ID: 8844628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the dietary amount and source of protein, resistance training and anabolic-androgenic steroids on body weight and lipid profile of rats.
    Aparicio VA; Sánchez C; Ortega FB; Nebot E; Kapravelou G; Porres JM; Aranda P
    Nutr Hosp; 2013; 28(1):127-36. PubMed ID: 23808440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of androgenic-anabolic steroids.
    Melchert RB; Welder AA
    Med Sci Sports Exerc; 1995 Sep; 27(9):1252-62. PubMed ID: 8531623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
    Nieschlag E; Vorona E
    Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging.
    Golestani R; Slart RH; Dullaart RP; Glaudemans AW; Zeebregts CJ; Boersma HH; Tio RA; Dierckx RA
    Eur J Clin Invest; 2012 Jul; 42(7):795-803. PubMed ID: 22299602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study.
    Henriksen HCB; Havnes IA; Jørstad ML; Abdullah R; Thorsby PM; Hauger LE; Edvardsen T; Haugaa KH; Almaas VM; Bjørnebekk A
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14554. PubMed ID: 38268076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions.
    Falqueto H; Júnior JLR; Silvério MNO; Farias JCH; Schoenfeld BJ; Manfredi LH
    Rev Endocr Metab Disord; 2021 Jun; 22(2):161-178. PubMed ID: 33783694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users.
    Souza FR; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Lima TP; Ferreira FD; Oliveira TF; Yonamine M; Takayama L; Pereira RMR; Negrão CE; Passarelli M; Rochitte CE; Alves MJNN
    Atherosclerosis; 2019 Apr; 283():100-105. PubMed ID: 30826541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis.
    Chang S; Münster AB; Gram J; Sidelmann JJ
    Semin Thromb Hemost; 2018 Nov; 44(8):734-746. PubMed ID: 30267392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Central Effects of Androgenic-anabolic Steroid Use.
    Mędraś M; Brona A; Jóźków P
    J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B; Jansen T; Grabbe S
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.
    Onakomaiya MM; Henderson LP
    Psychopharmacology (Berl); 2016 Feb; 233(4):549-69. PubMed ID: 26758282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular implications of anabolic steroid abuse.
    Cheever K; House MA
    J Cardiovasc Nurs; 1992 Jan; 6(2):19-30. PubMed ID: 1729424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids.
    Cohen LI; Hartford CG; Rogers GG
    Med Sci Sports Exerc; 1996 Feb; 28(2):176-9. PubMed ID: 8775151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review.
    Rohman L
    Eat Disord; 2009; 17(3):187-99. PubMed ID: 19391018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.